Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cancergencyto.2004.10.012 | DOI Listing |
Mol Carcinog
February 2025
Department of Hematopathology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China.
Mixed phenotype acute leukemia (MPAL) is a rare type of acute leukemia (AL), MPAL with BCR::ABL1 fusion is the main subtype of MPAL, mainly affecting adult males. It is an acute leukemia with unique clinical and biological characteristics that involve both the myeloid and lymphatic systems. Gene fusion plays a crucial role in the pathogenesis, diagnosis, prognosis assessment, and treatment of leukemia.
View Article and Find Full Text PDFSurg Pathol Clin
December 2024
Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, 445 Great Circle Road, Office 1959, Nashville, TN 37228, USA.
Int Cancer Conf J
October 2024
Division of Head and Neck Surgery, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo Nagaizumi-Cho Sunto-Gun, Shizuoka, 411-8777 Japan.
Biphenotypic sinonasal sarcoma (BSNS) is a double-phenotype sarcoma that shows differentiation in both the nervous and muscular systems. To date, whole-genome and transcriptome sequencing (WGTS) has not been used to analyze BSNS. We report a patient with BSNS who was diagnosed based on rearrangement using WGTS.
View Article and Find Full Text PDFOncol Lett
December 2024
School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402306, Taiwan, R.O.C.
The present study reports the potential of furosemide therapeutic activity in acute myeloid leukemia. A 26-year-old man with acute biphenotypic leukemia was treated with furosemide for suspected pulmonary edema, which was later deemed to be an infiltration of leukemia cells. Notably, the myeloblast population was rapidly eliminated during furosemide therapy.
View Article and Find Full Text PDFNat Commun
September 2024
Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Despite recent work linking mixed phenotype acute leukemia (MPAL) to certain genetic lesions, specific driver mutations remain undefined for a significant proportion of patients and no genetic subtype is predictive of clinical outcomes. Moreover, therapeutic strategy for MPAL remains unclear, and prognosis is overall poor. We performed multiomic single cell profiling of 14 newly diagnosed adult MPAL patients to characterize the inter- and intra-tumoral transcriptional, immunophenotypic, and genetic landscapes of MPAL.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!